Page last updated: 2024-08-24

fluorodeoxyglucose f18 and 4-hydroxymethylphenidate

fluorodeoxyglucose f18 has been researched along with 4-hydroxymethylphenidate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brockmann, K; Globas, C; Hauser, TK; Machulla, HJ; Reimold, M; Rolfs, A; Schöls, L; Walter, U1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and 4-hydroxymethylphenidate

ArticleYear
PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:7

    Topics: Adult; Age of Onset; Brain; Dopamine Agents; Dopamine Antagonists; Dopaminergic Neurons; Female; Fluorodeoxyglucose F18; Glucose; Heterozygote; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methylphenidate; Middle Aged; Mutation; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Spinocerebellar Ataxias

2012